Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation

被引:0
|
作者
LI Min ZHANG Li-ping YANG Lu Department of Anesthesiology.Peking University Third Hospital
机构
关键词
liver transplantation; fluid therapy; coagulation; blood;
D O I
暂无
中图分类号
R657.3 [肝及肝管];
学科分类号
1002 ; 100210 ;
摘要
Background There have been many studies investigating the impact of the model for end-stage liver disease(MELD)score on predicting post-transplant outcome.But it is unclear whether MELD is correlated to intraoperative fluid therapyand coagulation status.We investigated the relationship between the severity of liver diseases as measured by MELDscore and intraoperative fluid requirements and the changes of coagulation characteristics.Methods Ninety patients were included in this retrospective study.The patients were stratified into three groupsaccording to the MELD scores:<15(low),15-25(medium)and>25(high).Intraoperatively,volume was restored withallogeneic and/or salvaged red blood cells(RBC),fresh-frozen plasma(FFP),platelet and other types of fluids accordingto hemodynamic data,hematocrit,and clotting data.Intraoperative coagulation data,blood requirements and other fluidsadministered were compared among the 3 groups.Results Before surgery,in addition to the three variables used to calculate MELD scores in other baseline laboratoryvalues,including ratio of activated partial thromboplastin time(R-APTT),D-Dimer,hematocrit,platelet and blood ureanitrogen(BUN)were significantly different among the 3 groups.The blood loss increased with increasing MELD.Thevolume of RBC(allogeneinc,salvaged and total),FFP,platelet and the total volume of transfusion were also significantlydifferent among the three groups(P<0.01).The requirements for prothrombin complex and fibrinogen showed a similarpattern.During operation,the changing trends of each coagulation variable were different.Compared with baseline,during each intraoperative stage,INR and R-APPT increased in the low MELD group.While in the medium MELD andhigh MELD groups,INR did not changed significantly during the operation,and R-APPT significantly increased only afterrepeffusion.Conclusions This study provided some useful information for perioperative management of patients undergoing livertransplantation.Careful preoperative planning and resource preparation are crucial for patients with high MELD scores.Close communication between surgeon,anesthesiologist and the transfusion staff of blood bank before and duringsurgery should be stressed.
引用
收藏
页码:1963 / 1968
页数:6
相关论文
共 50 条
  • [31] Diagnostic dilemma of coagulation problems in an HIV-positive patient with end-stage liver disease undergoing liver transplantation
    Ali Abdullah
    Ibtesam A Hilmi
    Raymond Planinsic
    World Journal of Transplantation, 2015, (01) : 34 - 37
  • [32] Estimation of nitric oxide metabolites in patients with end stage liver disease (ESLD) undergoing orthotopic liver transplantation
    Hilmi, I
    Chhibber, A
    Lustik, S
    Kolano, J
    Thorborg, P
    Hare, EO
    ANESTHESIOLOGY, 1997, 87 (03) : A112 - A112
  • [33] BLOOD CARNITINE STATUS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS WITH END-STAGE LIVER-DISEASE
    PALOMBO, JD
    BORUM, PR
    JENKINS, RL
    TREY, C
    BISTRIAN, BR
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (03): : 504 - 507
  • [34] Endoscopic stenting of gallbladder for symptomatic cholelithiasis in patients with end-stage liver disease awaiting orthotopic liver transplantation
    Shrestha, R
    Bilir, BM
    Everson, GT
    Steinberg, SE
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (03): : 595 - 598
  • [35] A COMPARISON BETWEEN HETEROTOPIC AND ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS WITH END-STAGE CHRONIC LIVER-DISEASE
    METSELAAR, HJ
    HESSELINK, EJ
    DERAVE, S
    GROENLAND, THN
    BAKKER, CM
    WEIMAR, W
    SCHALM, SW
    TERPSTRA, OT
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1531 - 1532
  • [36] Coagulation Management in End-Stage Liver Disease
    Shashank S. Shettar
    Kofi Vandyck
    Kenichi A. Tanaka
    Current Anesthesiology Reports, 2022, 12 : 297 - 306
  • [37] Orthotopic liver transplantation reverses the adverse nutritional changes of end-stage liver disease in children
    Holt, RIG
    Broide, E
    Buchanan, CR
    Miell, JP
    Baker, AJ
    Mowat, AP
    MieliVergani, G
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (02): : 534 - 542
  • [38] Serum leptin in pediatric end-stage liver disease and following successful orthotopic liver transplantation
    Roberts, GA
    Holt, RIG
    Ghatei, MA
    Baker, AJ
    Bloom, SR
    MieliVergani, G
    Miell, JP
    HEPATOLOGY, 1997, 26 (04) : 866 - 866
  • [39] Coagulation Management in End-Stage Liver Disease
    Shettar, Shashank S.
    Vandyck, Kofi
    Tanaka, Kenichi A.
    CURRENT ANESTHESIOLOGY REPORTS, 2022, 12 (02) : 297 - 306
  • [40] RISK OF OCCULT CARCINOMAS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER-TRANSPLANTATION FOR END-STAGE LIVER-DISEASE SECONDARY TO PRIMARY SCLEROSING CHOLANGITIS
    DELCORE, R
    EISENACH, JB
    PAYNE, KM
    BHATIA, P
    FORSTER, J
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (02) : 1883 - 1884